Bekanamycin
ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: aminodeoxykanamycin, Kanamycin B, kanendomycin, Nebramycin V
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Bekanamycin is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including fabH and fabH.
- Molecular targets: fabH and fabH (2 listed in DrugCentral).
- ATC code: J01GB13 (Other aminoglycosides).
- Molecular formula: C18H37N5O10; molecular weight 483.52 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | fabH | unknown | IC50 5.25 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | fabH | unknown | IC50 5.20 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01GB13 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › AMINOGLYCOSIDE ANTIBACTERIALS › Other aminoglycosides |
Chemical structure
| Molecular formula | C18H37N5O10 |
|---|---|
| Molecular weight | 483.52 g/mol |
| CAS number | 4696-76-8 |
| InChIKey | SKKLOUVUUNMCJE-FQSMHNGLSA-N |
| PubChem CID | 439318 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Bekanamycin work?
Its molecular targets in DrugCentral include fabH and fabH.
What is the chemical formula of Bekanamycin?
Bekanamycin has the molecular formula C18H37N5O10 and a molecular weight of 483.52 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1520 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL176 — compound record and bioactivity
- PubChem CID 439318 — chemical identifiers
- DrugBank DB13673 — drug record
- FDA UNII 15JT14C3GI — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.